Meet Ben: From Drug Discovery to Leading Innovation in Boston Ben Schwartz, VP of Oncology, shares his 20-year GSK journey, from drug discovery to leading research.

GSK has a significant footprint in the US across commercial, R&D, manufacturing, and corporate functions. We employ ~15,000 people across the US and have two corporate hubs.

Unfortunately, we cannot provide comprehensive information about our products here, in compliance with regulations. If you are a healthcare professional, you can access more …

GSK is a company where outstanding people can thrive. We prioritize innovation in vaccines and specialty medicines, maximizing the increasing opportunities to prevent and treat disease.

At GSK, we unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, …

GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227, receives US FDA Breakthrough Therapy Designation in late-line relapsed or refractory osteosarcoma Regulatory designation …

Mar 9, 2025 · GSK plc (LSE/NYSE: GSK) announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, will be …

For over 70 years, GSK has been tackling infectious diseases. Encompassing two-thirds of our pipeline, our extensive infectious disease portfolio includes vaccines, antibiotics, antivirals, and …

Contact us online at GSK for You. RRC - a reimbursement support program that helps patients and healthcare professionals in the US with coverage, coding and reimbursement issues for …

Life at GSK We are transforming our culture to create an environment where individuals and teams are inspired to be ambitious for patients